MASTER RESEARCH SERVICES AGREEMENT (For Selected Products)Master Research Services Agreement • June 28th, 2024 • Artiva Biotherapeutics, Inc. • Biological products, (no disgnostic substances) • New York
THIS MASTER RESEARCH SERVICES AGREEMENT (the “Agreement”) is made as of August 3, 2020 (the “Effective Date”), by and between ARTIVA BIOTHERAPEUTICS, INC., a Delaware corporation, having an address of 4747 Executive Drive, Suite 1150, San Diego, CA 92121 (“Artiva”), and GREEN CROSS LABCELL CORPORATION, a Korean corporation, with its principal place of business at 107, Ihyeon-ro 30 beon-gil, Giheung-gu, Yongin-si, Gyeonggi-do, 446-850, 16924, Republic of Korea (“GCLC”).
MASTER RESEARCH SERVICES AGREEMENTMaster Research Services Agreement • December 30th, 2014 • Spark Therapeutics, Inc. • Biological products, (no disgnostic substances) • Pennsylvania
This Master Research Services Agreement (this “Agreement”) is made this 14th day of October, 2013 (the “Effective Date”) by and between The Children’s Hospital of Philadelphia, with a principal address at 34th Street and Civic Center Boulevard, Philadelphia, Pennsylvania (“CHOP”), and AAVenue Therapeutics, LLC, a Delaware limited liability company with a principal address at 34th Street and Civic Center Boulevard, Philadelphia, Pennsylvania (“AAVT”). CHOP and AAVT may each be referred to herein as a “Party” and together as the “Parties”.
MASTER RESEARCH SERVICES AGREEMENTMaster Research Services Agreement • July 15th, 2024 • Gelteq LTD • Pharmaceutical preparations
MASTER RESEARCH SERVICES AGREEMENT BY AND BETWEENMaster Research Services Agreement • August 15th, 2020
This Master Research Services Agreement (“Agreement”) is entered into on the date of last signature to this Agreement (“Effective Date”) by and between
MASTER RESEARCH SERVICES AGREEMENTMaster Research Services Agreement • April 27th, 2023 • Cannabis Bioscience International Holdings, Inc. • Services-commercial physical & biological research
This Master Research Services Agreement ("Agreement") is entered into as of the date of last signature hereto (the "Effective Date") by and between:
Dated 04 February 2014 Kitov Pharmaceutical Limited AND Java Clinical Research Limited Master Research Services AgreementMaster Research Services Agreement • July 20th, 2015 • Kitov Pharmaceuticals Holdings Ltd. • Pharmaceutical preparations
MASTER RESEARCH SERVICES AGREEMENTMaster Research Services Agreement • July 28th, 2020
Name: MCCRAE RESEARCH LIMITED (“MRL”) Company no. 5863408 Address: 181 Grafton Road Grafton Auckland NZ 1010 Contact Person: Kevin Ross Phone: +64 2777 12337 Contact Email: kevin.ross@orionhealth.com Fax:
Amendment No.1 to Master Research Services Agreement By and Between The Children’s Hospital of Philadelphia and Spark Therapeutics, Inc.Master Research Services Agreement • March 14th, 2016 • Spark Therapeutics, Inc. • Biological products, (no disgnostic substances)
This amendment is made and entered into March 10, 2016 (the “Effective Date”) by and between The Children’s Hospital of Philadelphia, a Pennsylvania nonprofit corporation with its principal place of business at 34th Street and Civic Center Boulevard, Philadelphia, PA 19104 (“CHOP”) and Spark Therapeutics, Inc., (formerly known as AAVenue Therapeutics, LLC) a Delaware corporation with its principal place of business at 3737 Market Street, Suite 1300, Philadelphia, PA 19104 (“Spark Therapeutics”) (the “Amendment”).
